TUBERCULOSIS INFECTION, LATENT
Clinical trials for TUBERCULOSIS INFECTION, LATENT explained in plain language.
Never miss a new study
Get alerted when new TUBERCULOSIS INFECTION, LATENT trials appear
Sign up with your email to follow new studies for TUBERCULOSIS INFECTION, LATENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Early TB pill for kids could stop infection before it starts
Prevention Recruiting nowThis study tests whether giving tuberculosis (TB) preventive medicine right away to children and teens who live with a TB patient can stop them from getting infected. About 647 kids aged 5 to 17 will be split into two groups: one gets the medicine immediately, the other gets stan…
Matched conditions: TUBERCULOSIS INFECTION, LATENT
Phase: NA • Sponsor: Pontificia Universidad Catolica de Chile • Aim: Prevention
Last updated May 13, 2026 16:03 UTC
-
Shorter TB prevention pill regimens aim to boost completion and safety
Prevention Recruiting nowThis study tests whether shorter daily pill regimens (1–2 months) can safely prevent latent tuberculosis infection from turning into active disease. About 1,800 adults and children with a positive TB test will take one of several experimental pill combinations or the standard 4-m…
Matched conditions: TUBERCULOSIS INFECTION, LATENT
Phase: PHASE2, PHASE3 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Prevention
Last updated Apr 24, 2026 16:18 UTC